HFCL Limited

Technology — Communication Equipment · NSE

₹256.01+₹12.19 (+5.00%)

DalalBaazaar Score

44 / 100

🟡 Moderate

Verdict

CAUTION

Risk

Moderate

Driven by negative free cash flow, a very high earnings multiple, which leaves little margin for disappointment.

In simple words: The business is earning a fairly low return on the money invested in it, with both sales and profits growing well. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:08 pm

Caution warranted. Multiple fundamental metrics — flagged in red below — point to either valuation stretch, leverage risk, or weakening profitability. This doesn't mean avoid the stock outright, but it does mean the burden of proof is on the growth story to justify the current price.

Understanding the Business

Company site ↗

The 60-second version of HFCL Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

HFCL Limited manufactures and sells telecom products in India and internationally.

IndustryCommunication Equipment

SectorTechnology

Employees1,820

Annual revenue₹4,928 Cr

How does it make money?

Turns over ₹4,928 Cr a year. Of every ₹100 of sales, about ₹6 reaches shareholders as profit, with ₹16 left at the operating level before interest, tax and depreciation. Each of its 1,820 employees supports ₹2.71 Cr of revenue a year, the signature of a capital- or asset-led business.

EBITDA margin15.8%

Net margin6.3%

Revenue / employee₹2.71 Cr

Who are its competitors?

The closest listed comparisons in its industry are TATA CONSULTANCY SERV LT, INFOSYS LIMITED, HCL TECHNOLOGIES LTD, WIPRO LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

TATA CONSULTANCY SERV LTP/E 17.3x · ROE 45.6%

INFOSYS LIMITEDP/E 15.8x · ROE 32.0%

HCL TECHNOLOGIES LTDP/E 20.4x · ROE 24.6%

WIPRO LTDP/E 14.5x · ROE 15.9%

What is its competitive advantage?Little sign of one

Returns on capital of 10.8% are at or below what the capital likely costs. That is the financial pattern of a business competing largely on price, where advantage has to come from execution rather than position.

ROCE10.8%

ROE6.4%

Peer median ROE32.0%

What is the outlook?

2 analysts covering the stock expect revenue to grow about 5.6% and earnings to grow about 2.6% in the year to 2028. These are estimates by people who follow the company, not a forecast for the wider industry.

Est. revenue growth+5.6%

Est. earnings growth+2.6%

Analysts2

What has been driving growth?

Growth has come mainly from selling more, rather than from keeping more of each sale. Over 3 years revenue moved +4% while net margin moved -0% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+4%

Margin effect-0%

DalalBaazaar Score

44/ 100

Moderate

Weighted across six categories. Every point is explained below.

✗ P/E of 66.7x is demanding — it needs sustained high growth to justify
✗ P/E is 21% above its own historical median of 55.1x — expensive by its own standards
✗ P/B of 7.72x is a steep premium to book

Quality vs. Valuation

Company Quality

47/ 100

Average

How good the business is, ignoring the share price entirely.

Valuation

23/ 100

Expensive

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

66.7x

3Y Median

55.1x

40 monthly readings · mean 63.5x · range 29.9x–173.0x

Sector Median

16.5x

median of 4 sector peers

⚠️Current valuation is approximately 21% above its 3y median of 55.1x. Paying more than usual needs a reason — faster growth, a better balance sheet, or a re-rating you believe in.

⚠️Against its sector it trades 303% above the peer median of 16.5x.

vs. its own history

Expensive

55.1x median over 40 months · +21%

vs. sector peers

Expensive

16.5x median of 4 peers · +303%

vs. generic bands

Expensive

Above 35x

P/E (Trailing)

66.7x

P/B

7.72x

EV/EBITDA

52.6x

PEG

56.55

Dividend Yield

0.08%

What's Good / What's Bad

🟢 What's Going Well2

Margins are improving
EBITDA margin is up from 12.6% to 15.8% over 3 years.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention6

Debt is rising
Total debt is up 103% over 3 years — worth checking what it funded.
Free cash flow is negative
The business is not currently covering its capital spending from operations.
Return on equity is falling
ROE has dropped from 9.7% to 6.4% — each rupee of shareholder capital earns less than it did.
Return on capital is falling
ROCE has declined from 15.4% to 10.8% — often a sign of competition or overexpansion.
Inventory building faster than sales
Inventory is up 87% against revenue growth of 4% — stock may not be moving.
Valuation above its historical average
At 66.7x the stock trades 21% above its own median of 55.1x.

Red Flags

4 items require attention · 4 high

🔴Debt has risen sharplyFinancial
Total debt is up 103% over 3 years, from ₹936 Cr to ₹1,896 Cr.
🔴Free cash flow negative for 4 yearsFinancial
The business has not covered its capital spending from operations for several years running, which has to be funded externally.
🔴Profit up while operating cash flow fallsFinancial
Reported profit rose but cash generated by operations declined — worth checking whether earnings are being supported by non-cash items or working capital.
🔴Inventory building faster than salesFinancial
Inventory up 87% against revenue up 4% — stock may not be moving.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Margin expansion has further to run
EBITDA margin has risen from 12.6% to 15.8%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

The price already assumes success
The stock trades 21% above its own median multiple. At this level the business has to deliver just to stand still, and a stumble is repriced twice — lower earnings on a lower multiple.
Growth barely outpaces inflation
Revenue compounding at 1.3% a year is close to the rate prices rise, so the business is gaining little ground in real terms. That leaves the share price dependent on a re-rating rather than on earnings growth.
Returns on shareholder capital are falling
ROE has dropped from 9.7% to 6.4%. Each rupee of equity earns less than it did, so profit growth increasingly depends on raising more capital rather than on the existing base working harder.
Several serious flags at once
4 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1EBITDA margin holds above 14%✓ 15.8%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Debt / EBITDA stays below 2x✗ 2.4x
The ratio lenders write covenants against; it survives a small or negative equity base, unlike Debt/Equity.
3Free cash flow remains positive✗ -₹723 Cr
Profit that never becomes cash eventually stops being profit.
4Interest cover stays above 3x✓ 3.6x
How much operating profit can fall before interest stops being comfortably covered.
5Revenue growth stays above 4% a year✗ 1.3% CAGR
Latest reported year was 119.9%. The bar is set below the established compounding rate, so ordinary variation does not trip it.

Investment Checklist

6 / 12 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✗ Not trading at an extreme valuation (P/E < 40x)
✗ Not buying right at the 52-week high
✓ Analyst consensus isn't majority-sell
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

4 good · 3 neutral · 4 weak

Market Cap

₹39,176 Cr

Mid Cap

Mid-sized — more growth headroom, but sharper swings than large caps

P/E (Trailing)

66.7x

Expensive

Expensive — verify against sector peers

P/B Ratio

7.72x

Rich

Steep premium to book — needs high, durable returns to justify

EPS (TTM)

₹3.84

Profitable

Profitable on a per-share basis

ROE

6.4%

Weak

Weak capital efficiency

ROCE

10.8%

Moderate

Moderate return on the capital in the business

Debt/Equity

0.38x

Low

Conservative leverage

Revenue Growth (YoY)

119.9%

Healthy

Healthy top-line growth

Profit Growth (YoY)

75.7%

Healthy

Profits growing at a healthy clip

Dividend Yield

0.08%

Modest

Small cash return — most of the return has to come from the price

Free Cash Flow

-₹723 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹256.01

P/E (Forward)

32.0x

Improving

Below the trailing multiple — the street expects earnings to grow into the price

Operating Margin

18.9%

Good

Healthy core-business profitability

Net Margin

9.6%

Average

Average bottom-line conversion

Current Ratio

1.99

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.99

Market-like

Moves roughly in line with the market

52W Range Position

91%

Near high

Near its 52-week high

Technical Snapshot

SMA 20 / SMA 50

238.3 / 232.6

Bullish alignment (short > long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

67.8

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹4,735 Cr	₹4,458 Cr	₹4,057 Cr	₹4,928 Cr	+1.3%
EBITDA	₹597 Cr	₹603 Cr	₹430 Cr	₹781 Cr	+9.4%
EBITDA Margin	12.6%	13.5%	10.6%	15.8%	—
PAT (Net Profit)	₹301 Cr	₹330 Cr	₹177 Cr	₹312 Cr	+1.2%
EPS	₹2.18	₹2.33	₹1.23	₹2.13	-0.8%
ROE	9.7%	8.3%	4.3%	6.4%	—
ROCE	15.4%	12.3%	7.1%	10.8%	—
Total Debt	₹936 Cr	₹991 Cr	₹1,522 Cr	₹1,896 Cr	+26.5%
Free Cash Flow	-₹106 Cr	-₹455 Cr	-₹13 Cr	-₹723 Cr	—

🟡 Revenue has been broadly flat over 3 years (1.3% a year).

🟢 EBITDA has grown at 9.4% a year over 3 years.

🟢 EBITDA Margin has risen from 12.6% to 15.8% over 3 years (+3.2 pts).

🟡 PAT (Net Profit) has been broadly flat over 3 years (1.2% a year).

🟡 EPS has been broadly flat over 3 years (-0.8% a year).

🔴 ROE has fallen from 9.7% to 6.4% over 3 years (-3.3 pts).

🔴 ROCE has fallen from 15.4% to 10.8% over 3 years (-4.6 pts).

🔴 Total Debt has grown at 26.5% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹8,868 Cr

Total Liabilities

₹3,919 Cr

Total Debt

₹1,896 Cr

Cash & Equivalents

₹38 Cr

Operating Cash Flow

-₹378 Cr

Capex

-₹345 Cr

Shareholding (proxy)

Institutional Holding

20.1%

Insider Holding

34.2%

Corporate Actions

Dividend Rate

₹0.2

Ex-Dividend Date

22 Sept 2026

Analyst Consensus

Recommendations

2 Buy · 0 Hold · 0 Sell

Target Price (Mean)

₹265

+3.5% vs CMP

Target Range

₹150 – ₹380

Peer Comparison

Company	P/E	ROE
TATA CONSULTANCY SERV LT	17.3x	45.6%
INFOSYS LIMITED	15.8x	32.0%
HCL TECHNOLOGIES LTD	20.4x	24.6%
WIPRO LTD	14.5x	15.9%

Recent News

1 positive2 mixed3 general

HFCL Share Price Fall: Price Action and Fundamentals

Univest, 15 OctPrice move

🟡Mixed / dependsA price move rather than a change in the business. If the figures on this page have not moved, the fall is either an opportunity or news they have yet to catch up with.

Smallcap stocks under pressure; Sterlite, MTAR, HFCL, Netweb slide 5%

Business Standard, 15 Oct

HFCL shares jump 277% in 2026 ahead of Reliance Jio IPO; Nuvama says buy rating. Check target price and Jio connection

Livemint, 16 OctAnalyst view

🟢Potentially positiveAn analyst opinion changing, which moves the price without changing the business.

This stock just beat AI star HFCL’s 230% rally to top Nifty 500 gainers in 2026. Can outperformance last?

The Economic Times, 22 Sept

HFCL’s AI, data centre exposure drives Nuvama’s Buy call; target implies 56% upside

The Economic Times, 16 Oct

HFCL shares rally 15% in 3 sessions; analysts flag Rs 260 resistance, consolidation risk

Moneycontrol.com, 01 OctPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Watch Items

Trading very close to its 52-week high — momentum-driven entries here carry more mean-reversion risk.
Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

🟡Business QualityAdequate10.5/20

🟡Financial HealthAdequate11.8/20

🔴GrowthWeak7.4/20

🔴ProfitabilityWeak5.8/15

🔴ValuationDemanding3.3/15

🟡RiskModerate4.9/10

Unremarkable in both directions

A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 4 high-severity red flags sit above this conclusion and should be read first.

This thesis breaks if

✓EBITDA margin holds above 14%15.8%
✗Debt / EBITDA stays below 2x2.4x
✗Free cash flow remains positive-₹723 Cr
✓Interest cover stays above 3x3.6x
✗Revenue growth stays above 4% a year1.3% CAGR